Article

Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text
Advertising


Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates



Journal of the American Academy of Dermatology
Volume 14, n° 5P1
pages 785-791 (mai 1986)
Doi : 10.1016/S0190-9622(86)70094-7
Cyclosporin A
 

Elizabeth Heller Page, M.D., Denise M. Wexler, M.D., F.R.C.P.(C), Lyn C. Guenther, M.D., F.R.C.P.(C)
Department of Dermatology, University of Western Ontario. 

aReprint requests to: Dr. Lyn C. Guenther, 215 Wellington St., London, Ontario N6B 2L2, Canada.
@@#100979@@

Cyclosporin A is a new immunosuppressive agent that selectively affects T helper cells without suppressing the bone marrow. Cyclosporin A. has been used primarily to prevent rejection in organ transplantation and acute graftversus-host disease. Studies suggest that it may be of benefit in psoriasis, pemphigus vulgaris, bullous pemphigoid, Behçet's disease, and collagen vascular disorders. Since cyclosporin A has a potentially important use in dermatology, and since a number of dermatologic side effects are seen as a consequence of its use, it is important that dermatologists be familiar with this drug.

The full text of this article is available in PDF format.

Top of the page

© 1986  Published by Elsevier Masson SAS.
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline
You can move this window by clicking on the headline
@@#110903@@